Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

The drug-eluting stent (DES) has become one of the most successful and important medical devices for coronary heart disease, but yet suffers from insufficient endothelial cell (EC) growth and intima repair, eventually leading to treatment failure. Although biomacromolecules such as vascular endothel...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Jing Wang, Yunfan Xue, Jun Liu, Mi Hu, He Zhang, Kefeng Ren, Yunbing Wang, Jian Ji
Formato:	Artigo
Idioma:	English
Publicado em:	American Association for the Advancement of Science (AAAS) 2020-01-01
Colecção:	Research
Acesso em linha:	http://dx.doi.org/10.34133/2020/1458090

Registos relacionados

Ureteral stent technology: Drug-eluting stents and stent coatings
Por: Luo Yang, et al.
Publicado em: (2015-10-01)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
Por: Josep Gomez‐Lara, et al.
Publicado em: (2021-11-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
Por: E. Y. Zagorulko, et al.
Publicado em: (2019-01-01)

Development of drug-eluting stent coated with PLGA nanoparticles as drug carriers
Por: Yusuke Tsukada, et al.
Publicado em: (2013-12-01)

Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents
Por: Qing Ma, et al.
Publicado em: (2021-12-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
Por: Hang Ouyang, et al.
Publicado em: (2021-04-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
Por: Jing Wang, et al.
Publicado em: (2021-12-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
Por: Walid Maamoun
Publicado em: (2013-09-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
Por: А. Н. Кудряшов, et al.
Publicado em: (2017-04-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
Por: Paweł Gąsior, et al.
Publicado em: (2018-11-01)

Long-Term Clinical Outcomes of Polymer-Free Sirolimus-Eluting Stent and Polymer-Coated Sirolimus-Eluting Stent in Patients with Type 2 Diabetes
Por: Yang O, et al.
Publicado em: (2024-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Por: Juntao Yin, et al.
Publicado em: (2023-01-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
Por: Yi-Xing Yang, et al.
Publicado em: (2020-01-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
Por: I. Rykowska, et al.
Publicado em: (2020-10-01)

Drug Release Analysis and Optimization for Drug-Eluting Stents
Por: Hongxia Li, et al.
Publicado em: (2013-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
Por: Michał Hawranek, et al.
Publicado em: (2021-12-01)

Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
Por: Zhu, Xiaoxiang, et al.
Publicado em: (2017)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
Por: Masaki Hirose, et al.
Publicado em: (2023-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
Por: Matthew G. Whitbeck, et al.
Publicado em: (2013-01-01)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Por: Ahmed Abdelaziz, et al.
Publicado em: (2024-11-01)

Chiral Separation of Apremilast by Capillary Electrophoresis Using Succinyl-β-Cyclodextrin—Reversal of Enantiomer Elution Order by Cationic Capillary Coating
Por: Zoltán-István Szabó, et al.
Publicado em: (2023-04-01)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
Por: Nina Peng, et al.
Publicado em: (2020-01-01)

Studies of biodegradable drug-eluting tracheal stents
Por: Ng, Anthony Herr Cheun
Publicado em: (2012)

Drug-Eluting Stents: Technical and Clinical Progress
Por: Maciej Koźlik, et al.
Publicado em: (2023-02-01)

Drug-eluting stents: long-term safety
Por: Yu A Karpov, et al.
Publicado em: (2009-05-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
Por: Imad Sheiban, et al.
Publicado em: (2008-02-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
Por: Sohila Refahi, et al.
Publicado em: (2019-03-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
Por: Xiao-Fang Tang, et al.
Publicado em: (2018-08-01)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
Por: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Publicado em: (2015)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
Por: Jonathan Hanna, et al.
Publicado em: (2023-04-01)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Por: Cheng-Hsuan Tsai, et al.
Publicado em: (2022-06-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
Por: Ali S. Almasood, et al.
Publicado em: (2011-01-01)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
Por: Yinping Zhao, et al.
Publicado em: (2021-02-01)

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
Por: Spadaccio Cristiano, et al.
Publicado em: (2016-01-01)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
Por: Fong, Timothy Ren Zhong
Publicado em: (2015)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
Por: Sacharias von Koch, et al.
Publicado em: (2024-12-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
Por: Iraj Jafaripour, et al.
Publicado em: (2023-05-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Por: Porto, I, et al.
Publicado em: (2005)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
Por: Yi-Xing Yang, et al.
Publicado em: (2023-01-01)

A Case Summary of the Application of a Drug-Eluting Stent Combined with a Drug-Coated Balloon in Left Main Coronary Artery Disease
Por: Rong-Xue Xiao, et al.
Publicado em: (2022-04-01)